Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection
NCT00265408 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2014-12-08
Summary
Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection.
Conditions
Interventions
- DRUG
- DRUG
-
warfarin
Sponsors & Collaborators
-
University of California, San Diego
lead OTHER
Principal Investigators
-
Matt B Jensen, MD · UCSD Stroke Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-12-31
- Completion
- 2007-03-31
Countries
- United States
Study Locations
More Related Trials
-
Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).
NCT05868525 ·Status: RECRUITING ·Phase: PHASE4
-
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
NCT02144831 ·Status: WITHDRAWN ·Phase: PHASE4
-
Recurrent Carotid Stenosis
NCT00000527 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events
NCT01923818 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Aortic Arch Related Cerebral Hazard Trial (ARCH)
NCT00235248 ·Status: COMPLETED ·Phase: PHASE3
-
Warfarin and Coronary Calcification Project
NCT00868712 ·Status: COMPLETED
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events
NCT01924325 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
NCT01668901 ·Status: WITHDRAWN ·Phase: PHASE4
-
High-Shear Microfluidic Thrombosis Assay
NCT02422810 ·Status: COMPLETED
-
Platelet Hyperreactivity to Aspirin and Stroke
NCT00766896 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate Safety and Tolerability of a Single Dose of AZD6482
NCT00688714 ·Status: COMPLETED ·Phase: PHASE1
-
Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
NCT05247931 ·Status: UNKNOWN
-
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
NCT00041938 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Interaction Study Between AZD3480 and Warfarin
NCT00689637 ·Status: COMPLETED ·Phase: PHASE1
-
the Safety and Efficacy of Antiplatelet Therapy in Patients of CAA
NCT04654026 ·Status: UNKNOWN
-
Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery
NCT02209909 ·Status: COMPLETED ·Phase: NA
-
Testing a Community Intervention to Increase Aspirin Use
NCT02607917 ·Status: COMPLETED ·Phase: NA
-
INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority
NCT02832544 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
NCT02415400 ·Status: COMPLETED ·Phase: PHASE4
-
Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin
NCT01452568 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation
NCT03839355 ·Status: TERMINATED ·Phase: PHASE3
-
Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
NCT00748371 ·Status: TERMINATED ·Phase: PHASE4
-
A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin
NCT01214122 ·Status: WITHDRAWN ·Phase: PHASE1
-
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT00501345 ·Status: TERMINATED ·Phase: PHASE3